The COVID-19 vaccine trial marks a landmark initiative in the race against the pandemic, enabled by the UK Government’s approval.Set to begin in January 2021, this revolutionary “human challenge trial” involves meticulously infecting paid volunteers with the Coronavirus to expedite vaccine efficacy research.
The COVID-19 vaccine trial represents a groundbreaking approach to accelerating the vaccine development process during a critical moment in public health.Approved by the UK Government, this pioneering initiative will utilize a human challenge trial methodology, where volunteers are intentionally infected with the Coronavirus to test vaccine efficacy.